Christopher G. Hayes - 05 Jul 2022 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
VRCA
Transactions as of
05 Jul 2022
Net transactions value
+$11,999
Form type
4
Filing time
05 Jul 2022, 16:13:59 UTC
Previous filing
25 Feb 2022
Next filing
11 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Purchase $11,999 +5,714 +229% $2.10 8,214 05 Jul 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.